Trial Profile
Effectiveness of Liraglutide in comparison to Lixisenatide in patients with Type 2 Diabetes Mellitus :data from The Health Improvement Network (THIN) database in United Kingdom
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 May 2017
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary) ; Lixisenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms THIN
- 16 May 2017 New trial record
- 01 Apr 2017 Results published in the Diabetes Therapy